1. Home
  2. GRFS vs RXO Comparison

GRFS vs RXO Comparison

Compare GRFS & RXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • RXO
  • Stock Information
  • Founded
  • GRFS 1940
  • RXO 2022
  • Country
  • GRFS Spain
  • RXO United States
  • Employees
  • GRFS 23737
  • RXO N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • RXO
  • Sector
  • GRFS Health Care
  • RXO
  • Exchange
  • GRFS Nasdaq
  • RXO Nasdaq
  • Market Cap
  • GRFS 5.5B
  • RXO 4.5B
  • IPO Year
  • GRFS 2006
  • RXO N/A
  • Fundamental
  • Price
  • GRFS $8.05
  • RXO $26.49
  • Analyst Decision
  • GRFS Sell
  • RXO Hold
  • Analyst Count
  • GRFS 2
  • RXO 17
  • Target Price
  • GRFS $10.50
  • RXO $26.47
  • AVG Volume (30 Days)
  • GRFS 1.3M
  • RXO 793.7K
  • Earning Date
  • GRFS 01-01-0001
  • RXO 02-06-2025
  • Dividend Yield
  • GRFS N/A
  • RXO N/A
  • EPS Growth
  • GRFS N/A
  • RXO N/A
  • EPS
  • GRFS 0.27
  • RXO N/A
  • Revenue
  • GRFS $7,814,096,584.00
  • RXO $3,861,000,000.00
  • Revenue This Year
  • GRFS $8.86
  • RXO $15.99
  • Revenue Next Year
  • GRFS $7.00
  • RXO $50.95
  • P/E Ratio
  • GRFS $35.12
  • RXO N/A
  • Revenue Growth
  • GRFS 7.21
  • RXO N/A
  • 52 Week Low
  • GRFS $5.30
  • RXO $18.75
  • 52 Week High
  • GRFS $12.15
  • RXO $32.82
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 51.40
  • RXO 36.96
  • Support Level
  • GRFS $7.29
  • RXO $28.02
  • Resistance Level
  • GRFS $7.85
  • RXO $29.60
  • Average True Range (ATR)
  • GRFS 0.33
  • RXO 0.96
  • MACD
  • GRFS 0.06
  • RXO -0.29
  • Stochastic Oscillator
  • GRFS 77.22
  • RXO 0.54

About GRFS Grifols S.A.

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.

About RXO RXO Inc.

RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the largest component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement our truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operating segment operate within the transportation industry and in primarily the same geography North America.

Share on Social Networks: